Abstract
The spread of the severe acute respiratory syndrome coronavirus has changed the lives of people around the world with a huge impact on economies and societies. The development of wearable sensors that can continuously monitor the environment for viruses may become an important research area. Here, the state of the art of research on biosensor materials for virus detection is reviewed. A general description of the principles for virus detection is included, along with a critique of the experimental work dedicated to various virus sensors, and a summary of their detection limitations. The piezoelectric sensors used for the detection of human papilloma, vaccinia, dengue, Ebola, influenza A, human immunodeficiency, and hepatitis B viruses are examined in the first section; then the second part deals with magnetostrictive sensors for the detection of bacterial spores, proteins, and classical swine fever. In addition, progress related to early detection of COVID‐19 (coronavirus disease 2019) is discussed in the final section, where remaining challenges in the field are also identified. It is believed that this review will guide material researchers in their future work of developing smart biosensors, which can further improve detection sensitivity in monitoring currently known and future virus threats.
Keywords: artificial intelligence, biosensors, data analytics, detection properties, electromagneto‐mechanical design, Internet of Things, machine learning, piezoelectric/magnetostrictive materials, virus
Piezoelectric and magnetostrictive biosensor materials are presented and discussed. It is found that these advanced materials show great potential for application in the detection of various viruses. Progress related to COVID‐19 (coronavirus disease 2019) and the way to new and emerging sensors for virus detection for home application or wearability are considered.
1. Introduction
In December 2019, an acute febrile illness with a severe respiratory distress syndrome began to appear, and an evolving situation was reported involving infection with a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2).[ 1 ] Most patients with SARS‐CoV‐2 experience fever with or without chills, chest tightness, dry cough, and shortness of breath, while developing patchy to diffuse infiltration of the lungs, as shown radiographically in Figure 1 . Identifying and monitoring SARS‐CoV‐2 infection has become crucially important. A recent projection of the transmission dynamics of SARS‐CoV‐2[ 2 ] showed that longitudinal serological studies are desperately needed to determine the extent and duration of immunity to SARS‐CoV‐2. Even in the event of apparent elimination, maintenance of SARS‐CoV‐2 surveillance is still needed because of a possible resurgence of contagion.
In the past, notable viruses have emerged suddenly from obscurity or anonymity, provoking concern from the point of view of immunology regarding their sustained epidemic transmission in naive human populations. More than 70% of these infections have been zoonotic, entering either directly from wild animal reservoirs or indirectly via an intermediate domestic animal host.[ 3 ] Ebola virus, avian influenza, human immunodeficiency virus (HIV), and SARS are all examples of zoonoses that have emerged from wild animals, presenting an increasingly serious threat to human health and economies worldwide. Figure 2 shows the trend in the number of people infected with SARS‐CoV‐2.[ 4 ]
Early assessment of etiologic agents, such as viruses, is imperative for clinical point of care (POC). In medical diagnostics, virus recognition can be performed in laboratories using traditional methods, such as polymerized chain reaction (PCR) amplification and enzyme‐linked immunoassays, both of which require biological labels, such as radioisotopes, enzymes, and fluorophores, which can be readily detected using various analytical techniques. Although these methods are extremely sensitive and selective, it is common to employ multiple detection layers for several analytes. The need to engage highly trained staff, long analytical times, and the huge investment in effort and resources often hamper diagnosis. Considering the different diagnostic applications, there is an urgent need for effective virus sensors that are small and easy to operate and offer rapid response times as well as high selectivity, cross‐sensitivity, and portability.[ 5 ]
Biosensors are described as compact analytical devices, incorporating biological or biomimetic sensing elements, and are applied for the detection and monitoring of various analytes or pathogens that are important for the environment, health, and food industries.[ 6 ] Biosensors must meet the requirements of sensitivity, response accuracy, reproducibility, high specificity toward the desired target element, nontoxicity, and cost‐effectiveness.[ 7 ] Biosensors can be divided into various groups, such as optical, piezoelectric, and electrochemical. Figure 3 presents an overview of the main approaches using transducers in biosensors. The simplest type of biosensor is an optical transducer,[ 8 ] which can detect the analyte or pathogen as a measured change in the fluorescence, absorption, or reflectance performance of the sensing material. Figure 3a shows the fluorescence spectra of a semiconducting polyelectrolyte nanocomplex with and without exosomes (Exo.), as involved in pathogenesis‐including neurodegenerative diseases, viral/bacterial infections, and cancer. This technique simply takes advantage of the color change of the sensing materials when their size or concentration changes due to interaction with the analyte or pathogen. The second class of biosensors is the micromechanical transducer; the basis of this method is the measurement of changes in the resonance frequency.[ 5 ] Quartz crystal microbalance (QCM) with piezoelectric properties, benefits from frequency changes (see Figure 3b) or deflection of the sensing material. The third class of biosensors is the electrochemical biosensor, which can be classified as amperometric, potentiometric, impedimetric, or conductometric.[ 9 , 10 ] Figure 3c shows a schematic illustration of an electrochemical sensor and the responses of square‐wave voltammetry of this sensor at concentrations of 0, 4, 6, 8, and 10 ng mL−1 of total prostate‐specific antigen (PSA). Graphene oxide/Au nanoparticles/antitotal PSA antibody is attached to the surface of the working electrode for antigen capture. The resulting antigen/antibody‐modified electrode is subsequently incubated with the prepared graphene oxide/Au nanoparticles/anti‐free PSA antibody to form a sandwich‐like system. The limit of detection of this biosensor is related to the large specific surface area of graphene oxide and the high electrochemical current of Au. It should be noted that in addition to the above three biosensors, other devices such as microfluidic,[ 11 ] plasmonic,[ 12 ] cantilever‐based[ 13 , 14 ] and field‐effect transistor (FET)‐based electronic[ 15 , 16 ] biosensors have been developed.
Regarding the coronavirus disease 2019 (COVID‐19) pandemic that has never been experienced before in the 21st century, Ji et al.[ 17 ] summarized the structure of SARS‐CoV‐2, its genomic and gene expression characteristics, the current progress of SARS‐CoV‐2 ribonucleic acid (RNA), antibodies, antigens, and virus detection. Morales‐Narváez and Dincer[ 18 ] outlined innovative diagnostic methods for targeting a variety of COVID‐19‐related biomarkers. By measuring prognostic biomarkers and combining this knowledge with clinical observations and risk factors, patients can be stratified according to disease severity, so Russell et al.[ 19 ] proposed the ideal features of the biosensors that can be regarded as a key player in precision medicine for COVID‐19. On the other hand, research and development of biosensors that can detect at an early stage with high sensitivity and low cost have been conducted. However, none of these are commercially available on the market, and cannot be used for pandemic diseases such as COVID‐19.[ 20 ] Seven main recommendations have been suggested to the biosensing community (Figure 4 ).[ 18 , 20 ] Recently, Samson et al.[ 21 ] highlighted an overview of the traditional viral detection methods, and recent trends and future perspectives of biosensors for the detection of SARS‐CoV‐2.
Herein, the emphasis is on the piezoelectric materials since their coupled electromechanical properties[ 22 ] make them well‐suited for use as sensors and actuators in smart structures and devices. In the past two decades, a wide range of piezoelectric ceramics and composites[ 23 , 24 ] have been studied by the Tohoku University research group. Piezoelectric materials have also become important biomaterials that can be interfaced with biological tissues and used in miniaturized bioelectronic and biochemical devices.[ 25 ] Meanwhile, magnetostrictive materials can convert magnetic energy into mechanical energy or the reverse,[ 26 , 27 ] and are used to build sensors and actuators. In the past decade, works on magnetostrictive alloys and composites, including clad plates,[ 28 ] short wire composites,[ 29 ] and long wire composites,[ 30 ] have been reported by our group. A new type of active magnetostrictive material has also been introduced as a biological sensor platform[ 31 ] in recent years.
Piezoelectric ceramics/polymers and magnetostrictive alloys are examples of functional materials, which are promising energy‐harvesting materials.[ 32 , 33 ] Functional composite materials and energy‐harvesting technologies play an important role in building the Internet of Things (IoT) society.[ 34 , 35 , 36 ] After the SARS‐CoV‐2 pandemic, environmental monitoring will become even more important. Also expected to gain importance is detection and monitoring of damage in composite materials[ 37 , 38 ] using electromagnetic sensors. Indeed, it is desirable to develop virus sensors that do not require power sources or batteries. Piezoelectric and magnetostrictive biosensors seem to exhibit superior performance to that of other biosensors (see Table 1 ).[ 39 , 40 ] Optimal composite design will also ensure that the piezoelectric and magnetostrictive biosensors meet the requirements illustrated in Figure 4. However, further research progress is required; although the piezoelectric and magnetostrictive sensors can detect the viruses from frequency changes, these sensors have a potential to detect directly using the output voltage. In addition, they are expected to be combined with piezoelectric and magnetostrictive energy‐harvesting devices for the IoT, with the possibility to identify viruses by monitoring mechanical vibration. They can also be attached or embedded in smart clothing. Herein, we briefly discuss several human viruses with the main focus on piezoelectric and magnetostrictive materials of a layered configuration and energy‐harvesting capabilities, aiming to provide insights into the development of more sensitive virus sensors. Attention is drawn to the sensor material itself, whereas the receptor linked to the sensor that confers specificity to the detection is out of scope for the present review.
Table 1.
Approach | Advantage | Disadvantage |
---|---|---|
Piezoelectric |
Rapid Highly sensitive Specific Label‐free |
Rely on sample preparation Complex pretreatment steps Brittleness |
Magnetostrictive |
Rapid Highly sensitive Specific Label‐free Simple configuration Wireless Easy fabrication |
Pick‐up coil Eddy current (it limits the high frequency applications) |
PCR |
Sensitive Specific |
Complex pretreatment steps Failing to distinguish between viable and nonviable cells Sophisticated instruments |
Optical |
Rapid Sensitive Specific |
Complex pretreatment steps Sophisticated instruments |
Electrochemical |
Rapid Sensitive Label‐free Low cost |
Low stability and repeatability Low coping ability for complex clinical samples |
2. Piezoelectric Biosensors
A piezoelectric material exhibits a mechanical oscillation under an alternating current (AC) voltage, producing an oscillating electric field. When a mass m increases due to the interactions between molecules, the frequency f controlled by the AC voltage decreases. Mass response‐type piezoelectric sensors are commonly used for virus detection. A schematic illustration of the operation principle of the piezoelectric biosensor is shown in Figure 5 . Probe antibodies are fixed on the upper electrode surface of the piezoelectric material as shown in Figure 5a. The upper and lower electrodes drive the resonation of the piezoelectric material. Target antigen then binds with the probe antibodies. The mass change Δm on the electrode surface leads to a time‐dependent frequency shift (see Figure 5b) that is represented by the frequency change Δf (Figure 5c) of the material in the oscillation circuit.[ 41 ] Mainly anisotropic materials such as aluminum nitride (AlN),[ 42 , 43 , 44 ] zinc oxide (ZnO),[ 45 , 46 ] barium titanate (BaTiO3),[ 47 , 48 , 49 ] lead titanate (PbTiO3),[ 50 , 51 , 52 ] quartz (SiO2),[ 53 , 54 ] and poly(vinylidene fluoride) (PVDF)[ 55 , 56 ] are used as sensor materials.[ 57 ] Table 2 lists the Young's modulus E, shear modulus μ, Poisson's ratio ν, mass density ρ, longitudinal piezoelectric coefficient d 33, and transverse piezoelectric coefficient d 31 of each of these materials.
Table 2.
E [GPa] | μ [GPa] | ν | ρ [g cm−3] | d 33 [pC N−1] | d 31 [pC N−1] | |
---|---|---|---|---|---|---|
AlN | 308.3[ 42 ] | 130.8[ 42 ] | 0.179[ 42 ] | 3.26[ 43 ] | 6.72[ 44 ] | −2.71[ 44 ] |
ZnO | 112.2[ 45 ] | 42.2[ 45 ] | 0.336[ 45 ] | 5.53[ 45 ] | 12.3[ 46 ] | −5.12[ 46 ] |
BaTiO3 | 112[ 47 ] | 43[ 48 ] | 0.35[ 49 ] | 5.4[ 47 ] | 140[ 47 ] | −60[ 47 ] |
PbTiO3 | 213.7[ 50 ] | 84.3[ 50 ] | 0.26[ 50 ] | 7.52[ 51 ] | 79.1[ 52 ] | −23.1[ 52 ] |
SiO2 | 72.52[ 53 ] | 30.97[ 53 ] | 0.166[ 53 ] | 2.204[ 53 ] | d 11 = 2.3[ 54 ] | d 14 = −0.67[ 54 ] |
PVDF | 2[ 55 ] | 0.752[ 55 ] | 0.33[ 55 ] | 1.8[ 55 ] | −22[ 56 ] | 23[ 55 ] |
Sauerbrey[ 58 ] discovered the relation between the quartz oscillation frequency in thickness shear mode and change in surface mass. The Sauerbrey equation is given by Equation (1)
(1) |
where f 0 is the fundamental resonance frequency and A is the active area of the piezoelectric material. The QCM technique, a label‐free technology, has made great progress[ 59 ] and has been successfully applied in virus detection. QCM can exhibit extraordinary sensitivity to changes in resonance frequency, recording sub‐nanogram mass changes. The performance of the QCM is characterized using the mass sensitivity, which describes the shift in resonance frequency f 0 due to adsorption of virus particles and the mechanical quality factor (Q value) defining the sharpness of the resonance peak. The Q value approximated as
(2) |
where Δs is defined as the spread of the signal trace at a distance from the baseline equal to the magnitude divided by . A higher Q value means a sharper resonance peak, resulting in a higher precision in determining resonance frequency and a smaller minimum detectable frequency change. The Q value can be optimized by the sensor electrode size and shape.[ 60 ] Figure 6 shows three different AT‐cut 10 MHz quartz crystals together with the corresponding Q values in air and in a liquid environment.
Cantilever beams of microscale length and width and nanoscale thickness are also used as resonant sensors to detect a variety of biological and chemical entities.[ 13 ] The resonance frequency of such a cantilever can be approximated by[ 61 ]
(3) |
where m* = 0.24ρlwh and k = Eh 3 w/(4l 3) are the mass and spring constants of the cantilever, respectively, expressed as functions of the density ρ, Young's modulus E, length l, width w, and thickness h. The mass change of the beam in bending mode due to adsorption of virus particles is obtained by
(4) |
Figure 7a shows an example of the fabrication process method for a microelectromechanical mass‐sensor based on the cantilever beam, actuated using a piezoelectric ZnO thin film.[ 62 ] The beam stack consists of Si/SiO2/Pt/ZnO/Pt layers. First, Si wafers are cleaned and wafers are loaded in a thermal oxidation furnace for thermal SiO2 growth. The SiO2 layer is then patterned, and the Si windows are opened. The bottom Pt electrode (Pt‐B) is coated, and ZnO is deposited. After that, the top Pt electrode (Pt‐T) is coated, and the Si wafer is etched. Finally, the device structure is released, and the top window is opened. A selectively mass‐loading ZnO layer is deposited. Figure 7b,c shows the top view of bare and mass‐deposited cantilever beams, respectively.
2.1. Human Papilloma Virus: Group I
As the third most commonly occurring cancer in women, cervical cancer can be caused by human papillomavirus (HPV). HPV is a deoxyribonucleic acid (DNA) virus belonging to the Papillomaviridae family and is one of the most easily sexually transmittable viruses globally since millions of people have been infected with HPV at some point in their lives. It should also be noted that HPV viruses may have no effects in most people; however, some types can cause health problems such as genital warts or cancer. In February 2019, an HPV vaccine was introduced in 92 countries as part of a national vaccination program, but remains important to solve such problems as unstable vaccine supply, high delivery cost, and low seed rate still prevail. Given the prevalence of this virus, researchers focus on developing effective monitoring methods for high‐risk HPV communities.[ 63 ]
To identify the HPV in recurrent and original pathological biopsy samples, Fu et al.[ 64 ] used AT‐cut 10 MHz piezoelectric quartz crystal and fabricated piezoelectric genesensors. A method for the rapid detection of HPV using piezoelectric genesensors was developed, and the detection effectiveness was compared with those of conventional PCR‐dot blot hybridizations. The researchers assumed that the results obtained from the piezoelectric genesensors and PCR‐dot blot were almost identical. Dell'Atti et al.[ 65 ] combined DNA piezoelectric sensors with PCR to create label‐free DNA piezoelectric biosensors for detecting HPV from human cervical scraping specimens. They optimized the piezoelectric sensors with synthetic oligonucleotides and performed the tests on cervical scraping samples after PCR amplification. Reproducibility was expressed as the average coefficient of variation (CV%) for three samples, and a good reproducibility of approximately 10% was obtained. Chen et al.[ 66 ] designed an adjustable, stainless‐steel, metal‐clamping, piezoelectric sensor. They detected the hybridization of HPV PCR products and discussed the effect of temperature change on the frequency baseline stability. Their results showed that the change in frequency amplitude can reach Δf = 55 ± 7.4 Hz when the target product of 40 μL in an ice bath was added to 110 μL of the buffer. Prakrankamanant et al. combined the loop‐mediated isothermal amplification (LAMP) technique with QCM for real‐time detection of high‐risk HPV DNA type 58 (HPV‐58), most commonly found in Asian women.[ 67 ] AT‐cut 9 MHz piezoelectric quartz crystals with polished Au electrode coatings on both sides were used. The effect of the changes in temperature and viscosity on the QCM sensor during the PCR process was addressed, and the sensitivity was further increased. The system could detect HPV‐58 at 100 copies with Δf = 34 ± 3.6 Hz. However, the analyte in this method was in contact with the reusable sensor surface, which could lead to the risk of carryover contamination. It has also been reported that the diagnostic specificity is low (90.5%) because of disagreement in results of HPV‐58 positive by LAMP‐QCM but negative by the conventional LAMP technique. So, further research and development are required.
2.2. Vaccinia Virus: Group I
Vaccinia virus is the prototype virus of the orthopoxvirus genus in the family Poxviridae and is found in multiple infectious forms including intracellular mature virus.[ 68 ] QCM technology was applied for real‐time airborne detection and quick detection of vaccinia virus.[ 69 , 70 ] Kleo et al.[ 69 ] established a unique detection system for the identification of vaccinia virus by combining QCM detection techniques and PCR amplification. To ensure that the PCR products can be detected directly by the QCM‐based detection system, a pretreatment via denaturation (95 °C) and fast cooling down with precooled buffer (4 °C) was performed. The required analytical time for the new system was 15 min, which is less than those of the traditional methods. Lee et al.[ 70 ] developed a method for the real‐time detection of airborne vaccinia virus using an integrated QCM technique. The capture rate varied linearly with the concentration of the initial virus suspensions (8.5 × 108 to 8.5 × 1010 particles mL−1) at flow rates of 2.0 and 1.1 L min−1. The research demonstrated the potential of QCM on the detection of nanoscale biological entities in air.
2.3. Dengue Virus: Group IV
As a mosquito‐borne viral disease, dengue fever (DENV) has numerous patients.[ 71 ] Although it is of major public health concern in urban and semiurban areas, leading to thousands of deaths per year, the current detection procedures are cumbersome and time‐consuming.[ 72 , 73 ] Wu et al.[ 74 ] developed a dengue fever piezoelectric immunochip. They used a 10 MHz QCM consisting of an 8 mm AT quartz wafer placed between Au electrodes to detect dengue envelop protein (E protein) and nonstructural protein 1 (NS‐1 protein) in a viremia phase patient serum, and obtained a detection limit for the phosphate buffered saline (PBS) diluted samples. The immunochip failed to quantify dengue virus antigens in 1/1000 untreated samples, so they used the cibacron blue 3GA gel–heat denature (CB–HD) method and succeeded in reducing the dilution from thousandfold to hundredfold. They found that the CB–HD method was the most effective sample pretreatment technique, demonstrating detection limits as low as 1.727 µg mL−1 for E protein and 0.740 µg mL−1 for NS‐1 protein. Tai et al.[ 75 ] coated the QCM with molecularly imprinted polymers (MIP) specific to the NS‐1 protein of flavivirus including dengue virus serotypes. The advantages of this MIP‐QCM to detect dengue virus were high sensitivity (1–10 ng mL−1), short operation time (20–30 min per sample), and easy interpretation.
Chen et al.[ 76 ] established a circulating‐flow QCM biosensing method. Au nanoparticles (AuNPs) were integrated into AT‐cut 9 MHz piezoelectric quartz crystal. The specific oligonucleotide‐functionalized AuNP probes were used as both detection amplifiers and verifiers in this method. The temperature of the QCM system was maintained at 30 °C. The detection limit of the QCM instrument in liquid was 1 Hz, and the Δf = 1 Hz corresponded to Δm = 0.391 ng. In the nanoparticle application, this method was able to detect dengue virus cDNA in clinical blood samples at two plaque forming unit (PFU) per milliliter. A linear correlation (R 2 = 0.987) of the detection signal, i.e., Δf versus virus titration, was found over a concentration range from 2 to 2 × 106 PFU mL−1. Furthermore, the technique was label‐free and highly sensitive. Concentrations as low as 2 PFU mL−1 of DENV could be detected, compared to the 1–50 PFU mL−1 detection limit for fluorescent (i.e., not label‐free) real‐time PCR.
The commercialization of dengue virus sensors remains far from imminent due to remaining issues with clinical samples and the piezoelectric sensor itself.[ 77 ] Pirich et al.[ 78 ] proposed the functionalization of commercial piezoelectric sensors with cellulose nanocrystal (CN) thin films to anchor monoclonal immunoglobulin against NS‐1 dengue antigen. Figure 8a shows the atomic force microscopy (AFM) topography image of CN, while Figure 8b–f shows the AFM topography images of piezoelectric sensor surfaces. Since the Au surface (Figure 8b) is known to hinder stable CN adsorption, a preliminary step was performed, coating the sensor with polyethylenimine (PEI) (see Figure 8c). The CN film was then anchored as shown in Figure 8d. The CN film was activated by an injection of 1‐ethyl‐3‐(3‐dimethylaminopropyl) carbodiimide/N‐hydroxysuccinimide (i.e., EDC/NHS) solution as shown in Figure 8e, and a monoclonal immunoglobulin G (IgGNS1) solution was injected for immobilization (Figure 8f). QCM was used to assess both antigen recognition and the frequency change Δf of the immunochips during the assembly process. Interaction analyses of the activation of the CN thin films were also performed by a QCM with energy‐dissipation monitoring (QCM‐D). The system was found capable of detecting IgGNS1 in the range of 0.01–10 µg mL−1 by both QCM and QCM‐D. The detection limits were 0.32 µg mL−1 for QCM and 0.1 µg mL−1 for QCM‐D. Figure 8g shows the frequency change Δf over time during NS‐1 detection using the QCM‐D. QCM and QCM‐D apparatuses can be employed in NS‐1 recognition and show potential for more sensitive, faster, and/or less expensive diagnostic assays for dengue (Table 3 ).
Table 3.
2.4. Ebola Virus: Group V
Ebola virus was first identified in 1976, and thousands of people, including numerous health care workers, have died due to this disease.[ 79 ] Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness affecting humans and other primates. The virus is transmitted to people from wild animals (such as fruit bats, porcupines, and nonhuman primates) and then spreads in the human population through direct contact with the blood, secretions, organs, or other bodily fluids of infected people, and with surfaces and materials (e.g., bedding and clothing) contaminated with these fluids. The average EVD case fatality rate is around 50%. Case fatality rates varied from 25% to 90% in past outbreaks.[ 80 ] Rapid POC care detection of the Ebola virus could enable early quarantine and help halt pandemics.
Baca et al.[ 81 ] fabricated a surface acoustic wave (SAW) sensor and proposed a label‐free sensing system for the rapid detection of Ebola antigens at the POC without the need for added reagents, sample processing, or specialized personnel. The sensor chips were prepared using lithium tantalate (LiTaO3) wafers with inter‐digital transducers (IDTs). The piezoelectric substrate propagated horizontally polarized surface shear waves induced by application of an AC voltage (several hundred millivolts to several volts) to the IDTs at a high frequency between 80 and 400 MHz. Molecular interactions between virus and antibody emitted an acoustic wave leading to a change in the input frequency. That is, detection of Ebola virus resulted in a frequency increase, with phase shift values ranging from 0.20 ± 0.04° to 4.46 ± 0.86°. They observed a log–linear sensor response for Ebola viral particles, with a detection limit of 1.9 × 104 PFU mL−1. They predicted that the SAW sensor would greatly improve testing sensitivity for infectious Ebola virus. The SAW sensor phase shift response seems to perform well for an infectious Ebola sample. However, the characteristics of acoustic waves depend on the temperature, so attention must be paid to the measurement environment.
2.5. Influenza A Virus: Group V
New viruses are causing outbreaks, and old viruses grow stronger every day, influenza virus (types A, B, C, and D) among them. Hence, current sensing methods require continuous upgrading to manage the numerous growing challenges for virus diagnosis.[ 57 ] Influenza A virus, a general type, has high mutagenicity and infectivity and is the most prevalent and severe infection. Type A exhibits a route of transmission from person to person as well as from animal (bird, pig, horse, etc.) to person. Influenza B virus has a slower rate of change than type A and has relatively mild symptoms. Although infectivity is high, the infection route is from person to person, and it is less likely than type A to cause a high fever. Once influenza C viral immunity has been acquired, that immunity persists for life. Reinfection is reminiscent of the common cold. The influenza D is suggested to be one of the viruses responsible for bovine respiratory disease complex.
The influenza A virus is often discussed as a worldwide influenza epidemic. As the shape of the virus continues to evolve, acquired immunity performance drops, and strain prediction becomes more difficult for vaccine producers. Figure 9 shows changes in the number of people infected with the influenza A virus in Japan over the past 10 years. According to the World Health Organization, the A(H1N1)pdm09 strain, which is a new version of the H1N1 (commonly known as the Spanish flu), was responsible for the 2009 influenza pandemic. A part of H3 is known as the Hong Kong Cold. Since current methods for the diagnosis of influenza require specialized laboratory facilities and highly trained personnel and, in the case of viral culture, can take up to 14 days to obtain a definitive result, a QCM‐based sensor has been developed for the rapid detection of both influenza A and B viruses in laboratory‐cultured preparations and clinical samples.[ 82 ]
Jiang et al.[ 83 ] designed and fabricated Love wave SAW sensors with SiO2‐coated lithium niobate (LiNbO3) piezoelectric wafers for the detection of influenza A viral antigen. Figure 10a shows a schematic of the preparation of the active surface for the SAW sensors. Figure 10b,c shows the test setup. Figure 10d shows the phase changes measured for the SAW sensor exposed to PBS powder and H1N1 HA antigen solutions. A detection limit as low as 1 ng mL−1 was obtained for influenza A H1N1 HA antigen at room temperature. Erofeev et al.[ 84 ] described label‐free rapid detection of influenza A virus using Ag‐coated lead zirconate titanate (PZT) piezoelectric disks of 100 µm thickness. The disks, modified with synthetic sialylglycopolymers based on a polymer matrix, which biospecifically bind the haemagglutinin proteins on the influenza viruses, were inserted in a flowing virus suspension. Figure 11a–f shows the fabrication process of the PZT disk sensor. Label‐free detection of the virus was achieved by monitoring the shift in disk radial mode resonance frequency. Figure 11g presents differences between the resonance frequency shifts for influenza A virus concentrations of 0, 105, 106, and 107 virions mL−1. Label‐free detection of influenza A viruses at concentrations below 105 virions mL−1 was demonstrated. It was also shown that frequency shift is proportional to the surface stress induced by virus adsorption (Figure 11h). Furthermore, the sensitivity was found to be inversely proportional to the thickness of the resonator. Hence, by using a thinner PZT substrate, the sensitivity can easily be increased several‐fold. It is expected that this PZT disk sensor method for influenza A virus detection can be extended to home application.
2.6. Human Immunodeficiency Virus: Group VI
HIV was first documented as a dangerous blood‐borne pathogen in the early 1980s, and HIV detection methods have gradually improved in terms of both sensitivity and specificity.[ 85 ] HIV is a lentivirus that leads to acquired immunodeficiency syndrome (AIDS), and with increasing awareness of AIDS emerging as a global public health threat, a wide range of biosensors have been developed for early diagnosis of HIV infections.[ 86 ]
Properties of piezoelectric acoustic sensors using AT‐cut 20 MHz quartz wafer have been evaluated for HIV‐1 (nonspecific) versus HIV‐2 (specific) antibody–antigen interactions.[ 87 ] It has been shown that the introduced sensor is effective in detecting and distinguishing HIV‐2 from HIV‐1 antibodies with good selectivity. Lu et al.[ 88 ] fabricated a MIP‐coated QCM biomimetic sensor for the detection of HIV‐1‐related protein (glycoprotein 41(gp‐41)). It was found that the MIP film not only exhibited a strong affinity for the template peptide, but also could specifically bind the corresponding HIV‐1 protein. The detection limit was 2 ng mL−1.
PCR and antibody capture by an enzyme‐linked immunosorbent assay for HIV‐1 and HIV‐2 are time‐consuming and require sophisticated equipment that is not compatible with emergency POC requirements. Bisoffi et al.[ 89 ] developed a prototype biosensor based on functionalized piezoelectric materials with specific antibodies against HIV‐1 and HIV‐2. They prepared a new generation of biosensor chips with altered dimensions and an increased area occupied by the IDTs as wafers. They employed lithographic deposition and patterning of the IDT and the SiO2 waveguide layers, followed by cutting of the final format of the chips. While most other technologies require 30–60 min to detect a potential infection, the developed biosensor detected the presence of virus within 5 min, including the distinction between HIV‐1 and HIV‐2. Hence, this prototype biosensor may have the potential to be developed into a device for use in applications that require rapid and reliable testing for potential HIV infections in blood donors. HIV‐1 antigens were detected by the QCM using AuNPs as a signal enhancer.[ 90 ] The QCM sensor, consisting of cavity resonators constructed over a piezoelectric substrate, would accumulate electric charges in response to the applied stress. Four AuNPs of different sizes were prepared (see Figure 12a). Figure 12b shows the transmission electron microscopy (TEM) image of the resulting AuNPs, with average diameters of 21, 30, 63, and 126 nm. Figure 12c shows the effect of NP size on the detection signal. The target HIV‐1 antigen concentration was 1 ng mL−1. Streptavidin–Au with a size of 30 nm yielded the strongest signal. That is, using streptavidin–Au as an amplifier, a limit of detection of 1 ng mL−1 was reached.
2.7. Hepatitis B Virus: Group VII
Hepatitis B virus (HBV) infection is one of the most common health problems in the world.[ 91 ] Although billions of people suffer from HBV, effective medicine and treatment are unfortunately not found to cure chronic HBV infection. Therefore, detecting and monitoring HBV during the early stages of infection is of great importance. Xu et al.[ 92 ] developed a piezoelectric diaphragm‐based immunoassay chip using microfabrication technology to detect anti‐HBV and anti‐alpha‐fetoprotein (AFP). Firstly, a thin TiO2/Pt film was sputter‐deposited on the top side of a Si‐on‐insulator wafer as the bottom electrode. A thin PZT film was then deposited by a sol–gel deposition method, and the PZT film was wet‐etched. A Si3N4 layer was deposited, and the Ti/Pt top electrode was sputtered. Figure 13 shows optical and scanning electron microscopy (SEM) images of the fabricated sensor chip. The chip consists of eight individual sensors in a sandwich structure with a circular top electrode, a PZT diaphragm, and a bottom electrode, as shown in Figure 13a. Figure 13b presents the back‐side of the sensor array. Figure 13c shows a top‐view SEM image of one reaction chamber, while Figure 13d shows a cross‐sectional SEM view of the same. Figure 13e shows the processing time effect on the frequency change due to the binding activity of the antigen. For example, sensors 2 and 3 were kept in air for 30 min before applying antigen solution, and the frequency was measured after the interaction time. Sensors 1 to 4 successfully captured the antibodies, as shown in Figure 13f. A detection limit of 0.1 ng mL−1 was obtained from the frequency shift‐based calibration curves. The fabricated sensor chip could be used to simultaneously detect multiple analytes. Giamblanco et al.[ 93 ] described a single‐step, label‐free method to selectively detect the HBV genome. Au‐coated QCM crystals consisting of a Au layer with a chromium adhesion layer were used, and QCM‐D measurement was carried out. At a probe density of 4.0 × 1012 molecules cm−2, a sensitivity of tens of ng cm−2 could be obtained for the HBV target without using any amplification steps or labeling method.
To further improve detection performance, piezoelectric plate technology should be combined with other technologies such as sensitive membranes, microfluidics, and nanoparticles. By using a (Pb(Mg1/3Nb2/3)O3)0.65(PbTiO3)0.35 (i.e., PMN–PT) piezoelectric plate sensor coated with probe DNA, in situ detection of HBV double mutation (HBVDM) in urine has been previously discussed.[ 94 ] The PMN–PT layer coated with Au electrodes on the two major surfaces and encapsulated by thin electrical insulation is shown in Figure 14a. The binding of the target DNA from the biological fluid sample to the probe DNA on the piezoelectric plate sensor surface shifted the sensor length‐extension mode (Figure 14b) and width‐extension mode (Figure 14c) resonance frequencies. Figure 14d shows an optical microscopy image of the sensor. This piezoelectric plate sensor was shown to detect HBVDM with an analytical sensitivity of 60 copies mL−1. After the test, the sensor was examined using a fluorescence microscope, and the obtained fluorescence images from detection at mutation concentrations of 100 × 10−21 m (10−16 mol m−3), 1 × 10−18 m (10−15 mol m−3), 10 × 10−18 m, and 100 × 10−18 m are shown in Figure 14e–h, respectively. The blue and orange spots represent the mutation fluorescent reporter microspheres and wild type fluorescent reporter microspheres. The PMN–PT piezoelectric plate sensor was also able to detect double‐stranded HBVDM and K‐ras point mutation with a detection efficiency of 70% or better at concentrations as low as 10−19 m (10−16 mol m−3) against single‐stranded mutation detection at the same concentrations.[ 95 ]
3. Magnetostrictive Biosensors
The magnetostrictive microcantilever (MSMC) has been investigated as a remote biosensor platform[ 96 ] that works well in either air or liquid. The principle of the biosensor is based on the resonance frequency change Δf with the mechanical load change as described in Section 2. A schematic illustration of the operation principle of the MSMC is shown in Figure 15 . Probe antibodies are fixed on the upper biosensor chip as shown in Figure 15a. Due to the magnetostrictive effect, the application of an AC magnetic field using a driving coil as shown in Figure 15b induces an oscillation of the MSMC. The attachment of a mass load Δm such as an antigen to the sensor surface with probe antibodies lowers the resonance frequency (see Figure 15c). The oscillation results in an emission of a magnetic flux, and changes in the amplitude and phase signal of the oscillation lead to a magnetic flux change that can be detected using a pick‐up coil (Figure 15b). Metglas amorphous alloy,[ 97 , 98 , 99 ] Fe–Co alloy,[ 32 , 100 , 101 ] and cobalt ferrite (CoFe2O4) ceramics[ 102 , 103 , 104 ] are widespread materials for magnetostrictive applications. Table 4 lists the Young's modulus E, Poisson's ratio ν, mass density ρ, piezomagnetic constant , and magnetostriction λ values for these materials.
Table 4.
MSMC performance is characterized by the mass sensitivity and the Q value. For MSMCs made of a commercial magnetostrictive Metglas alloy, for example, the Q value can reach more than 500 when operated in air and 30 when operated in water.[ 96 ] In addition, the Q value of Metglas under multiharmonic resonance modes can be as high as 1000 in air and over 100 in water.[ 105 ] On the other hand, magnetoelastic particles composed of an amorphous iron–boron binary alloy exhibit a Q value of 656 in air.[ 106 ] Compared to piezoelectric microcantilevers, MSMCs have simple configurations.
For a thin sensor vibrating in its basal plane, the fundamental resonant frequency of the longitudinal vibrations is given by[ 98 ]
(5) |
If the mass increase is small compared to the initial mass ρlwh of the sensor, then the mass change of the plate in longitudinal mode due to adsorption of virus particles, according to the measured resonance frequency shift, is given by[ 107 ]
(6) |
Equation (6) shows that increasing mass on the sensor surface produces a linear reduction in resonance frequency. If the mass of a single virus is known in advance, the number or type of the virus can be identified from the change in frequency.
From Equation (6), it can be seen that the sensitivity (Δf/Δm) is proportional to the resonance frequency f 0 and inversely proportional to the magnetostrictive biosensor mass ρlwh. This feature does not apply to the piezoelectric biosensors (see Equation (1) or (4)). Smaller magnetostrictive biosensors have higher f 0 and lower ρlwh, leading to higher sensitivity. However, as the biosensor size decreases, the amplitude of the detected signal decreases and the signal‐to‐noise ratio decreases, making signal processing harder.[ 108 ] Theoretical results showed that the sensitivity depends on the mass distribution[ 109 ] and is proportional to the square of mode shape[ 110 ] of the sensor.
MSMC shows numerous advantages: 1) its actuation and sensing unit is wirelessly controlled; 2) its fabrication process is relatively easy; and 3) it works well in liquids.[ 31 ]
3.1. Bacterial Spore
The magnetostrictive platform has a unique advantage over conventional sensor platforms in that measurement is wireless and remote. This advantage is achieved by using the driving and pick‐up coils, as shown in Figure 15b.
A biosensor for the detection of bacterial spores has already been developed. Metglas 2826 MB alloy was used as the sensor platform. The composition is Fe40Ni38Mo4B18, with a theoretical saturation magnetostriction value of 11 ppm. The detection targets were yeast cell[ 96 ] and acid phosphatase.[ 111 , 112 ] This sensor was also used to detect Salmonella typhimurium bacteria. Guntupalli et al.[ 113 ] constructed a biosensor immobilizing a polyclonal antibody onto the surface of Metglas 2826 MB alloy, in order to detect S. typhimurium in air. Because the increased mass of S. typhimurium was very small compared to the initial mass of the biosensor, they determined the mass change due to the bacteria binding from Equation (6). They compared the density of bacteria cells calculated from Equation (6) and the density of bacteria cells measured by SEM, and obtained good agreement between the different methods. Detection limit of 5 × 103 colony forming unit (CFU) mL−1 was obtained for 15 µm thick sensor with size of 2 mm × 0.4 mm. Fu et al.[ 114 ] demonstrated the detection of S. typhimurium bacteria in water using the Cu/Metglas bilayer.
Johnson et al.[ 106 ] fabricated magnetoelastic particles composed of an amorphous iron–boron binary alloy Fe79B21 by sputtering onto a chromium and Au‐coated Si wafer, and explored functionality in the detection of Bacillus anthracis spores. They obtained a correlation between the actual number of spores bounded to the biosensor and the calculated mass increase based on the resonance frequency shift from the experiments. Li et al.[ 115 ] performed the in situ detection of B. anthracis spores in water in a real‐time manner using a Cu/Metglas bilayer. Li and Cheng[ 105 ] then showed that the sensitivity of the biosensor is strongly dependent on the location of the mass load. The detection of Escherichia coli [ 116 ] and B. Anthracis spores[ 117 ] in water has been reported using the Cu/Metglas bilayer. Biosensors for in situ detection of pathogenic bacteria in liquid has been developed using magnetostrictive Metglas particles.[ 39 , 118 ] S. typhimurium, Listeria monocytogenes, E. coli, and Staphylococcus aureus were characterized. In addition, Metglas 2826 MB alloy biosensors specific to S. typhimurium have been prepared by immobilizing antibody or phage as biorecognition elements onto the sensor.[ 119 ] It was demonstrated that bacteriophage immobilized sensors have much better thermal stability than antibody immobilized sensors. Table 5 summarizes the detection limit of the Metglas sensor as applied to various targets.[ 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 ]
Table 5.
Target | Detection limit | Ref. |
---|---|---|
S. typhimurium | 5 × 103 CFU mL−1 | [ 113 ] |
B. anthracis in water | 105 CFU mL−1 | [ 115 ] |
E. coli in water | 105 CFU mL−1 | [ 116 ] |
B. anthracis in water | 104 spores mL−1 | [ 117 ] |
Pathogens in water | 100 CFU mL−1 | [ 118 ] |
Octachlorostyrene | 2.8 × 10−9 m | [ 120 ] |
Human serum albumin | 0.039 µg mL−1 | [ 121 ] |
Carcinoembryonic antigen | 1 pg mL−1 | [ 122 ] |
3.2. Protein
The Metglas 2826 MB biosensor for the detection of glucose[ 108 ] has been developed. Recently, Sang et al.[ 121 ] designed small, cost‐effective, stable Metglas 2826 MB biosensor to detect human serum albumin (HSA) rapidly and specifically, with a detection limit as low as 0.039 µg mL−1 (Table 5). Figure 16 shows the magnetostrictive sensor and sensing system. Wang et al.[ 122 ] developed the Metglas nano‐biosensor for detecting carcinoembryonic antigen (CEA) by biological modification on the surface of the sensor platform. The nano‐biosensor had a linear response to the logarithmic CEA concentrations ranging from 2 pg mL−1 to 6.25 ng mL−1, with a detection limit of 1 pg mL−1 (Table 5) and a sensitivity of 105.05 Hz mL ng−1.
3.3. Classical Swine Fever: Group IV
Classical swine fever, which is caused by the swine fever virus (CSFV), is a serious, economically damaging disease of swine,[ 123 ] and CSFV detection has been extensively investigated in connection with economic damage to the pig industry. A magnetostrictive sensing system for the detection of CSFV has been published.[ 124 ] In that study, the magnetostrictive sensor platform was composed of Metglas 2826 alloy (Fe40Ni40P14B6). The experimental data showed a sensitivity of approximately 95 Hz mL µg−1 for the CSFV detection sensor, with a detection limit of 0.6 µg mL−1. A magnetostrictive sensor immobilized with E2 glycoprotein was developed to detect CSFV E2 antibodies.[ 125 ] Figure 17a–c shows a SEM image of the sensor's Au surface without and with functionalization, as well as the energy‐dispersive X‐ray spectroscopy (EDS) spectra for elemental analysis of the sensor surface before and after the immobilization of CSFV E2. It was found that the Au content decreases after CSFV E2 immobilization. On the other hand, E2 contains large quantities of carbon and oxygen due to the nature of the envelope glycoprotein, so it is clear that carbon and oxygen accumulation also increased dramatically after CSFV E2 immobilization. From Figure 17d, it was observed that the resonance frequency shift increases with increasing CSFV E2 antibody concentration. The sensor showed a linear response to the logarithm of CSFV E2 antibody concentration, with a sensitivity of 56.2 Hz mL µg−1 and a detection limit of 2.466 ng mL−1. This sensor constituted a low cost, high sensitivity, wireless method for the selective detection of CSFV E2 antibodies. This CSFV E2 study not only proposed a new method for antibody detection but also demonstrated the potential utility of the method in real‐life diagnosis.
4. Future Outlook
The research outcomes reported above have demonstrated the potential and benefits of piezoelectric and magnetostrictive materials in detecting specific viruses. Table 6 summarizes the various materials and methods. Near future work should further improve the accuracy and efficiency, reduce the tester size and weight, and enhance the wearability of virus sensors through the bespoke design and fabrication of multifunctional piezoelectric and magnetostrictive materials. For example, lamination of piezoelectric and magnetostrictive layers[ 126 ] or dispersions of magnetoelectric (ME) nanoparticles[ 127 ] (see Figure 18a) might be one area of interest. Figure 18b shows a TEM of ME composite made of the magnetostrictive core CoFe2O4 and piezoelectric shell BaTiO3. To achieve a design optimized for sensor performance and benefits, parametric studies need to be conducted through theoretical investigation[ 128 , 129 ] including multiphysics and multiscale numerical simulation.[ 130 , 131 , 132 ] Improving modeling accuracy could remarkably increase the efficiency of the structural optimization of computational interactions between mechanical and electromagnetic fields, thereby reducing the time and cost of manufacturing and tooling in experiments. At the same time, such enhancement would also help to determine the microscale/nanoscale mechanisms impacting both mechanical and electromagnetic behavior of the functional piezoelectric and magnetostrictive materials.
Table 6.
Material | Method | Virus type | Detection limit | Detection range | Detection time | Advantage | Disadvantage/future work | Ref. |
---|---|---|---|---|---|---|---|---|
Quartz | PCR | HPV | 55 ± 7.4 Hz | 39 min | Unable to set constant temperature below 10 °C | [ 66 ] | ||
LAMP‐QCM | HPV‐58 | 34 ± 3.6 Hz | 30 min |
Lipid detection; fast preparation; real‐time measurement |
Lower diagnostic specificity at 90.5% | [ 67 ] | ||
QCM‐D | DENV NS‐1 | 0.1 µg mL−1 | 0.01–10 µg mL−1 | More sensitive, fast and less expensive diagnostic assays | [ 78 ] | |||
QCM | HIV‐1 | 2 ng mL−1 | Easy preparation; high stability and sensitivity | [ 88 ] | ||||
QCM | HIV‐1 | 1 ng mL−1 | Low concentration limit | [ 90 ] | ||||
QCM‐D | HBV | ≈4.0 × 1012 molecules cm−2 | Without the need of amplification steps or labeling methods | Fabrication of biosensors able to detect in a single‐step process | [ 93 ] | |||
LiTaO3 | SAW | Ebola | 1.9 × 104 PFU mL−1 | 1.6 × 104 to 6.5 × 106 PFU mL−1 | Adaptable, label‐free and rapid detection | Portability and optimization for field use | [ 81 ] | |
SAW | HIV‐1; HIV‐2 |
12 50% tissue culture infective doses (TCID50s) for HIV‐1; 87 TCID50s for HIV‐2 |
5 min | Rapid and accurate detection | Testing the clinical sensitivity and specificity using larger cohorts of infected patient sera in blinded case‐control studies | [ 89 ] | ||
SiO2/LiNbO3 | SAW | Influenza A H1N1 | 1 ng mL−1 | Without compensation design at room temperature | [ 83 ] | |||
PZT | Piezo‐ glycopolymer receptor | Influenza A | 105 virions mL−1 | 15 min | Acceptable detection time; reproducibility for home appliance use | [ 84 ] | ||
Piezoreaction chamber |
Anti‐HBsAg; anti‐AFP |
0.1 ng mL−1 | 0.1–10 000 ng mL−1 | Less than 2 h | Simultaneously detect eight different analytes | Price reduction due to further miniaturization and optimization | [ 92 ] | |
PMN‐PT | Piezoprobe DNA | HBVDM | 60 copies mL−1 | 30 min | [ 94 ] | |||
Piezoprobe DNA | HBVDM; KRAS | As low as 10−16 mol m−3 | Highly specific in situ, amplification‐free and label‐free mutation detection | [ 95 ] | ||||
Metglas | Magnetostriction | CSFV | 0.6 µg mL−1 | Resonance frequency shift linearly proportional to CSFV concentration; simple circuit design; fast signal processing; visual liquid crystal display | [ 124 ] | |||
Magnetostriction | CSFV E2 | 2.466 ng mL−1 | Several min | US$ 0.001 per sensor; minimum skill; smaller size | [ 125 ] |
Here, some key guidelines are summarized for improving the performance of the piezoelectric and magnetostrictive biosensors:
It is desired to develop piezoelectric and magnetostrictive sensors that can detect the viruses from changes of the output voltage instead of the resonance frequency change, as mentioned in the Introduction. For the piezoelectric sensors, both driving and sensing electrodes are needed.[ 47 ] The benefit of this detection method is that it does not require fast Fourier transform (FFT) or discrete Fourier transform (DFT) analysis and will shorten the detection time. In order to increase the sensitivity (e.g., output voltage change with respect to the mass change), it is necessary to investigate and identify the optimum materials and structures and vibration mode by numerical simulation.
As mentioned earlier, the sensitivity varies depending on the distribution[ 109 ] and location[ 105 ] of the virus mass. Therefore, it is recommended to simulate the effects of the distribution and location of the mass on the sensitivity of the biosensor subjected to vibration. At this time, it is important to understand the locations of the stress concentration and strain concentration of the biosensors. This knowledge will provide an effective route to the design and optimization of the biosensor.
By designing a composite biosensor using piezoelectric and magnetostrictive materials, it will be possible to apply it coillessly or wirelessly depending on the application or situation. Combining with soft materials may solve the brittleness of piezoelectric element and the eddy current of magnetostrictive materials (see Table 1). Furthermore, taking advantage of the characteristics of composite layered materials, it will be possible to develop biosensors that detect multiple viruses simultaneously. Material/structure optimization can be achieved by numerical simulations accounting for material and geometric nonlinearities, heterogeneous microstructure and complex shapes.
In recent years, some new methods have been developed that can detect SARS‐CoV‐2, as shown in Figure 19a.[ 133 ] A new assay device for identifying both SARS‐CoV‐2 and other winter viruses including influenza A has also been developed.[ 134 ] It was reported that it could successfully analyze DNA and detect SARS‐CoV‐2 within 90 min in nonclinical settings without the need for supervision by a trained healthcare professional. In addition, the detection of SARS‐CoV‐2 in air has been investigated (Figure 19b).[ 135 ] It is estimated that IoT and artificial intelligence (AI) will have huge economic impacts by 2030 and will be increasingly in demand in the coming “postcorona society.” For example, IoT‐connected biosensors with AI may become ubiquitous.[ 136 , 137 ] Along similar lines, Figure 20a shows a proposed mobile health system. This system can be used for patient health monitoring with a constant recording and feedback approach, but it can also be extended to track and trace infections for public health protection.
Currently, the development of efficient and reliable piezoelectric and magnetostrictive based biosensors that detect SARS‐CoV‐2 is desired. In fact, the detection of SARS‐CoV using the piezoelectric immunosensor has been reported,[ 138 ] and implementation of the recently proposed surface chemistry on the quartz crystal surface of the QCM will allow the early detection of SARS‐CoV‐2 (see Figure 21a,b).[ 139 ] Exploration to implement these engineered surfaces on the MSMC surface is needed (Figure 21c). Both piezoelectric and magnetostrictive materials are also promising candidates for energy‐harvesting from ambient environmental sources to self‐power biosensors for virus detection and communication. Such an advance would open a novel avenue for autonomous, digitalized virus detection. It is desirable to integrate wearable biosensors with energy‐harvesters as self‐powering sources. Such multifunctional self‐powered sensing systems can potentially manage health by automatically accumulating and transmitting data, contributing greatly to the realization of a society in which people can live without fear of infection by various viruses. Figure 20b shows an example of such a future society. The connected IoT biosensor detects viral pathogens in the air. From the big data provided by numerous IoT biosensors, the spread of infection can be understood in real time, and its short‐term and long‐term impacts both locally and globally can be modeled in real time. Wearable actuators may be able to direct people in hazardous areas to escape. The power used may be harvested from the breeze flowing[ 23 ] through the air conditioning duct for 24 h in case of houses and underground malls. AI can potentially predict a disease's degree of spreading and severity. It is necessary for material researchers to cooperate with researchers from electrical/electronics and computer science fields to advance interdisciplinary investigation and better protect communities from various infectious diseases.
5. Concluding Remarks
Herein, we have systematically summarized and reported progress in piezoelectric and magnetostrictive materials applied to biosensors. Based on the published literature we collected, these materials show great potential to be used in the detection of various infectious viruses. In particular, sampling and detection of coronavirus in the air were discussed and are currently under intensive investigation. The intention of the article is to guide and assist material researchers to reexamine the design and performance of existing piezoelectric and magnetostrictive biosensors. It is hoped that the study will inform and assist these researchers to develop more effective and reliable sensors for virus detection with higher sensitivity and accuracy (ng per mL), smaller size and weight, and affordability, for home application or wearability in the near future (smart clothing). Such virus detection sensors will become reality with the further development of materials science and technological progress in AI, machine learning and data analytics.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements
The authors greatly acknowledge the support of this work by Japan Society for the Promotion of Science (JSPS), Core‐to‐Core Program, grant number: JPJSCCA20200005.
Biographies
Fumio Narita is currently a Professor at the Department of Frontier Sciences for Advanced Environment at Tohoku University in Japan. He is engaged in research to design and develop piezoelectric/magnetostrictive materials and structures in energy harvesting and self‐powered environmental monitoring. He is extensively using state‐of‐the‐art electromagneto‐mechanical characterization techniques in combination with computational multiscale modeling to understand the fundamental structure–property relations of complex multifunctional composite materials.
Zhenjin Wang is a Ph.D. student at the Department of Materials Processing at Tohoku University, Japan. She received a bachelor's degree from Beihang University, China, in 2017 and a master's degree from Tohoku University, Japan, in 2019. Her research interests lie in the design and fabricate new types of piezoelectric composites and magnetostrictive composites for use in energy harvesting, microelectromechanical system (MEMS)‐based sensor, and IoT applications.
Constantinos Soutis is Professor of Aerospace Engineering, the Head of the Aerospace Research Institute, and Director of the Northwest Composites Centre at the University of Manchester, UK. Prior to this, he has held academic positions at the University of Sheffield, Imperial College London, University of Leicester, University of Cambridge, and visiting Professorial posts at Massachusetts Institute of Technology (MIT) and University of South Carolina, USA. He is a Fellow of the Royal Academy of Engineering and leading authority on mechanics and failure of composites, with significant contributions on modeling damage mechanisms and structural health monitoring of multilayered composite structures.
Narita F., Wang Z., Kurita H., Li Z., Shi Y., Jia Y., Soutis C., A Review of Piezoelectric and Magnetostrictive Biosensor Materials for Detection of COVID‐19 and Other Viruses. Adv. Mater. 2021, 33, 2005448. 10.1002/adma.202005448
Contributor Information
Fumio Narita, Email: narita@material.tohoku.ac.jp.
Constantinos Soutis, Email: constantinos.soutis@manchester.ac.uk.
References
- 1. Xiao S.‐Y., Wu Y., Liu H., J. Med. Virol. 2020, 92, 464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Kissler S. M., Tedijanto C., Goldstein E., Grad Y. H., Lipsitch M., Science 2020, 368, 860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Afrough B., Dowall S., Hewson R., Clin. Exp. Immunol. 2019, 196, 157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cumulative cases of COVID‐19, https://coronavirus.jhu.edu/data/cumulative‐cases (accessed: July 2020).
- 5. Afzal A., Mujahid A., Schirhagl R., Bajwa S. Z., Latif U., Feroz S., Chemosensors 2017, 5, 7. [Google Scholar]
- 6. Velasco‐Garcia M. N., Mottram T., Biosyst. Eng. 2003, 84, 1. [Google Scholar]
- 7. Rezaei Z., Mahmoudifard M., J. Mater. Chem. B 2019, 7, 4602. [DOI] [PubMed] [Google Scholar]
- 8. Lyu Y., Cui D., Huang J., Fan W., Miao Y., Pu K., Angew. Chem., Int. Ed. 2019, 58, 4983. [DOI] [PubMed] [Google Scholar]
- 9. Akbari Jonous Z., Shayeh J. S., Yazdian F., Yadegari A., Hashemi M., Omid M., Eng. Life Sci. 2019, 19, 206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Chowdhury A. D., Takemura K., Li T.‐C., Suzuki T., Park E. Y., Nat. Commun. 2019, 10, 3737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Qin P., Park M., Alfson K. J., Tamhankar M., Carrion R., Patterson J. L., Griffiths A., He Q., Yildiz A., Mathies R., Du K., ACS Sens. 2019, 4, 1048. [DOI] [PubMed] [Google Scholar]
- 12. Mauriz E., Sensors 2020, 20, 4745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Faegh S., Jalili N., Sridhar S., Sensors 2013, 13, 6089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Mertens J., Cuervo A., Carrascosa J. L., Nanoscale 2019, 11, 17689. [DOI] [PubMed] [Google Scholar]
- 15. Jeong C. K., Jin H. M., Ahn J.‐H., Park T. J., Yoo H. G., Koo M., Choi Y.‐K., Kim S. O., Lee K. J., Small 2014, 10, 337. [DOI] [PubMed] [Google Scholar]
- 16. Jin X., Zhang H., Li Y.‐T., Xiao M.‐M., Zhang Z.‐L., Pang D.‐W., Wong G., Zhang Z.‐Y., Zhang G.‐J., Microchim. Acta 2019, 186, 223. [DOI] [PubMed] [Google Scholar]
- 17. Ji T., Liu Z., Wang G. Q., Guo X., Khan S. A., Lai C., Chen H., Huang S., Xia S., Chen B., Jia H., Chen Y., Zhou Q., Biosens. Bioelectron. 2020, 166, 112455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Morales‐Narváez E., Dincer C., Biosens. Bioelectron. 2020, 163, 112274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Russell S. M., Alba‐Patiño A., Barón E., Borges M., Gonzalez‐Freire M., de la Rica R., ACS Sens. 2020, 5, 1506. [DOI] [PubMed] [Google Scholar]
- 20. Bhalla N., Pan Y., Yang Z., Payam A. F., ACS Nano 2020, 14, 7783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Samson R., Navale G. R., Dharne M. S., 3 Biotech 2020, 10, 385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Nye J. F., Physical Properties of Crystals, Clarendon Press, Oxford: 1957. [Google Scholar]
- 23. Wang Z., Narita F., J. Appl. Phys. 2019, 126, 224501. [Google Scholar]
- 24. Narita F., Nagaoka H., Wang Z., Mater. Lett. 2019, 236, 487. [Google Scholar]
- 25. Chorsi M. T., Curry E. J., Chorsi H. T., Das R., Baroody J., Purohit P. K., Ilies H., Nguyen T. D., Adv. Mater. 2019, 31, 1802084. [DOI] [PubMed] [Google Scholar]
- 26. du Tremolet de Lacheisserie E., Magnetostriction: Theory and Applications of Magnetoelasticity, CRC Press, Boca Raton, FL: 1993. [Google Scholar]
- 27. Engdahl G., Handbook of Giant Magnetostrictive Material, Academic Press, San Diego, CA: 2000. [Google Scholar]
- 28. Yang Z., Nakajima K., Onodera R., Tayama T., Chiba D., Narita F., Appl. Phys. Lett. 2018, 112, 073902. [Google Scholar]
- 29. Wang Z., Mori K., Nakajima K., Narita F., Materials 2020, 13, 1494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Yang Z., Nakajima K., Jiang L., Kurita H., Murasawa G., Narita F., Mater. Des. 2019, 175, 107803. [Google Scholar]
- 31. Saberkari H., Ghavifekr H. B., Shamsi M., J. Med. Signals Sens. 2015, 5, 77. [PMC free article] [PubMed] [Google Scholar]
- 32. Narita F., Fox M., Adv. Eng. Mater. 2018, 20, 1700743. [Google Scholar]
- 33. Jia Y., J. Intell. Mater. Syst. Struct. 2020, 31, 921. [Google Scholar]
- 34. Alsaadi A., Shi Y., Pan L., Tao J., Jia Y., Compos. Sci. Technol. 2019, 178, 1. [Google Scholar]
- 35. Du S., Jia Y., Zhao C., Amaratunga G. A. J., Seshia A. A., IEEE Sens. J 2020, 20, 277. [Google Scholar]
- 36. Wang Z., Kurita H., Nagaoka H., Narita F., Compos. Sci. Technol. 2020, 199, 108331. [Google Scholar]
- 37. Li Z., Mohamed Nasr Saleh A. D. H., McCarthy E. D., Soutis C., Gibson A. A. P., Sloan R., Res. Nondestr. Eval. 2018, 29, 123. [Google Scholar]
- 38. Li Z., Haigh A., Soutis C., Gibson A., Wang P., Nondestr. Test. Eval. 2019, 34, 429. [Google Scholar]
- 39. Zhang K., Zhang L., Fu L., Li S., Chen H., Cheng Z.‐Y., Sens. Actuators, A 2013, 200, 2. [Google Scholar]
- 40. Chen Y., Wang Z., Liu Y., Wang X., Li Y., Ma P., Gu B., Li H., Eur. J. Clin. Microbiol. Infect. Dis. 2018, 37, 1021. [DOI] [PubMed] [Google Scholar]
- 41. Chen Y., Qian C., Liu C., Shen H., Wang Z., Ping J., Wu J., Chen H., Biosens. Bioelectron. 2020, 153, 112049. [DOI] [PubMed] [Google Scholar]
- 42. Gerlich D., Dole S. L., Slack G. A., J. Phys. Chem. Solids 1986, 47, 437. [Google Scholar]
- 43. Tsubouchi K., Sugai K., Mikoshiba N., Proc. – IEEE Ultrasonics Symp., IEEE, Piscataway, NJ, USA: 1981, pp. 375–380. [Google Scholar]
- 44. Kamiya T., Jpn. J. Appl. Phys. 1996, 35, 4421. [Google Scholar]
- 45. Yoshimura H. N., Molisani A. L., Narita N. E., Manholetti J. L. A., Cavenaghi J. M., Mater. Sci. Forum 2006, 530–531, 408. [Google Scholar]
- 46. Kobiakov I. B., Solid State Commun. 1980, 35, 305. [Google Scholar]
- 47. Narita F., Shindo Y., Int. J. Metall. Mater. Eng. 2015, 1, 103. [Google Scholar]
- 48. Shindo Y., Tanaka K., Narita F., Acta Mech. 1997, 120, 31. [Google Scholar]
- 49. Marutake M., J. Phys. Soc. Jpn. 1956, 11, 807. [Google Scholar]
- 50. Kuma S., Woldemariam M. M., Adv. Condens. Matter Phys. 2019, 2019, 3176148. [Google Scholar]
- 51.Lead(II) Titanate, American Elements, https://www.americanelements.com/lead‐ii‐titanate‐12060‐00‐3 (accessed: June 2020).
- 52. Haun M. J., Furman E., Jang S. J., McKinstry H. A., Cross L. E., J. Appl. Phys. 1987, 62, 3331. [Google Scholar]
- 53. Hwa L.‐G., Lu C.‐L., Liu L.‐C., Mater. Res. Bull. 2000, 35, 1285. [Google Scholar]
- 54. Carr P. H., J. Acoust. Soc. Am. 1967, 41, 75. [Google Scholar]
- 55. Shindo Y., Domon W., Narita F., Theor. Appl. Fract. Mech. 1998, 28, 175. [Google Scholar]
- 56. Fay B., Lewin P. A., Ludwig G., Sessler G. M., Yang G., Ultrasound Med. Biol. 1992, 18, 625. [DOI] [PubMed] [Google Scholar]
- 57. Ravina A. D., Mohan H., Prasad M., Pundir C. S., Biosci. Rep. 2020, 40, BSR20193852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Sauerbrey G., Z. Phys. 1959, 155, 206. [Google Scholar]
- 59. Perumal V., Hashim U., J. Appl. Biomed. 2014, 12, 1. [Google Scholar]
- 60. Anderson H., Jonsson M., Vestling L., Lindberg U., Aastrup T., Sens. Actuators, B 2007, 123, 27. [Google Scholar]
- 61. Thundat T., Wachter E. A., Sharp S. L., Warmack R. J., Appl. Phys. Lett. 1995, 66, 1695. [Google Scholar]
- 62. Joshi P., Kumar S., Jain V. K., Akhtar J., Singh J., J. Microelectromech. Syst. 2019, 28, 382. [Google Scholar]
- 63. Mahmoodi P., Fani M., Rezayi M., Avan A., Pasdar Z., Karimi E., Amiri I. S., Ghayour‐Mobarhan M., BioFactors 2019, 45, 101. [DOI] [PubMed] [Google Scholar]
- 64. Fu W., Huang Q., Wang J., Liu M., Huang J., Chen B., Sens. Transducers Mag. 2004, 42, 214. [Google Scholar]
- 65. Dell'Atti D., Zavaglia M., Tombelli S., Bertacca G., Cavazzana A. O., Bevilacqua G., Minunni M., Mascini M., Clin. Chim. Acta 2007, 383, 140. [DOI] [PubMed] [Google Scholar]
- 66. Chen Q., Bian Z., Hua X., Yao C., Wu W., Zhang X., Zhang B., Huang J., Tang W., Fu W., Biosens. Bioelectron. 2010, 25, 2161. [DOI] [PubMed] [Google Scholar]
- 67. Prakrankamanant P., Leelayuwat C., Promptmas C., Limpaiboon T., Wanram S., Prasongdee P., Pientong C., Daduang J., Jearanaikoon P., Biosens. Bioelectron. 2013, 40, 252. [DOI] [PubMed] [Google Scholar]
- 68. Chung C.‐S., Chen C.‐H., Ho M.‐Y., Huang C.‐Y., Liao C.‐L., Chang W., J. Virol. 2006, 80, 2127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Kleo K., Kapp A., Ascher L., Lisdat F., Anal. Biochem. 2011, 418, 260. [DOI] [PubMed] [Google Scholar]
- 70. Lee J., Jang J., Akin D., Savran C. A., Bashir R., Appl. Phys. Lett. 2008, 93, 013901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Antunes P., Watterson D., Parmvi M., Burger R., Boisen A., Young P., Cooper M. A., Hansen M. F., Ranzoni A., Donolato M., Sci. Rep. 2015, 5, 16145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Su C.‐C., Wu T.‐Z., Chen L.‐K., Yang H.‐H., Tai D.‐F., Anal. Chim. Acta 2003, 479, 117. [Google Scholar]
- 73. Eivazzadeh‐Keihan R., Pashazadeh‐Panahi P., Mahmoudi T., Chenab K. K., Baradaran B., Hashemzaei M., Radinekiyan F., Mokhtarzadeh A., Maleki A., Microchim. Acta 2019, 186, 329. [DOI] [PubMed] [Google Scholar]
- 74. Wu T.‐Z., Su C.‐C., Chen L.‐K., Yang H.‐H., Tai D.‐F., Peng K.‐C., Biosens. Bioelectron. 2005, 21, 689. [DOI] [PubMed] [Google Scholar]
- 75. Tai D.‐F., Lin C.‐Y., Wu T.‐Z., Huang J.‐H., Shu P.‐Y., Clin. Chem. 2006, 52, 1486. [DOI] [PubMed] [Google Scholar]
- 76. Chen S.‐H., Chuang Y.‐C., Lu Y.‐C., Lin H.‐C., Yang Y.‐L., Lin C.‐S., Nanotechnology 2009, 20, 215501. [DOI] [PubMed] [Google Scholar]
- 77. Parkash O., Shueb R. H., Viruses 2015, 7, 5410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Pirich C. L., Alves de Freitas R., Torresi R. M., Picheth G. F., Sierakowski M. R., Biosens. Bioelectron. 2017, 92, 47. [DOI] [PubMed] [Google Scholar]
- 79. Frieden T. R., Damon I., Bell B. P., Kenyon T., Nichol S., New Eng. J. Med. 2014, 371, 1177. [DOI] [PubMed] [Google Scholar]
- 80.Ebola virus disease, https://www.who.int/health‐topics/ebola/#tab=tab_1 (accessed: July 2020).
- 81. Baca J. T., Severns V., Lovato D., Branch D. W., Larson R. S., Sensors 2015, 15, 8605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Hewa T. M. P., Tannock G. A., Mainwaring D. E., Harrisona S., Fecondo J. V., J. Virol. Methods 2009, 162, 14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Jiang Y., Tan C. Y., Tan S. Y., Wong M. S. F., Chen Y. F., Zhang L., Yao K., Gan S. K. E., Verma C., Tan Y.‐J., Sens. Actuators, B 2015, 209, 78. [Google Scholar]
- 84. Erofeev A. S., Gorelkin P. V., Kolesov D. V., Kiselev G. A., Dubrovin E. V., Yaminsky I. V., R. Soc. Open Sci. 2019, 6, 190255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Malm K., von Sydow M., Andersson S., Transfus. Med. 2009, 19, 78. [DOI] [PubMed] [Google Scholar]
- 86. Farzin L., Shamsipur M., Samandari L., Sheibani S., Talanta 2020, 206, 120201. [DOI] [PubMed] [Google Scholar]
- 87. Sheikh S., Blaszykowski C., Thompson M., Talanta 2011, 85, 816. [DOI] [PubMed] [Google Scholar]
- 88. Lu C.‐H., Zhang Y., Tang S.‐F., Fang Z.‐B., Yang H.‐H., Chen X., Chen G.‐N., Biosens. Bioelectron. 2012, 31, 439. [DOI] [PubMed] [Google Scholar]
- 89. Bisoffi M., Severns V., Branch D. W., Edwards T. L., Larson R. S., J. Clin. Microbiol. 2013, 51, 1685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Ly N., Park S., Park S. J., Sens. Actuators, B 2016, 237, 452. [Google Scholar]
- 91. Beasley R. P., Cancer 1988, 61, 1942. [DOI] [PubMed] [Google Scholar]
- 92. Xu T., Miao J., Wang Z., Yu L., Li C. M., Sens. Actuators, B 2011, 151, 370. [Google Scholar]
- 93. Giamblanco N., Conoci S., Russo D., Marletta G., RSC Adv. 2015, 5, 38152. [Google Scholar]
- 94. Kirimli C. E., Shih W.‐H., Shih W. Y., Analyst 2015, 140, 1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Kirimli C., Lin S., Su Y.‐H., Shih W.‐H., Shih W. Y., Biosens. Bioelectron. 2018, 119, 221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Li S., Orona L., Li Z., Cheng Z.‐Y., Appl. Phys. Lett. 2006, 88, 073507. [Google Scholar]
- 97. Tormes C. D., Beltrami M., Cruz R. C. D., Missell F. P., NDT&E Int. 2014, 66, 67. [Google Scholar]
- 98. Liang C., Morshed S., Prorok B. C., Appl. Phys. Lett. 2007, 90, 221912. [Google Scholar]
- 99. Wang Y., Hasanyan D., Li M., Gao J., Li J., Viehland D., IEEE Trans. Ultrason., Ferroelectr., Freq. Control 2013, 60, 1227. [DOI] [PubMed] [Google Scholar]
- 100. Yang Z., Kurita H., Takeuchi H., Katabira K., Narita F., Adv. Eng. Mater. 2019, 21, 1800811. [Google Scholar]
- 101. Narita F., Katabira K., Mater. Trans. 2017, 58, 302. [Google Scholar]
- 102. Bichurin M. I., Petrov V. M., Srinivasan G., Phys. Rev. B 2003, 68, 054402. [Google Scholar]
- 103. Thang P. D., Rijnders G., Blank D. H. A., J. Magn. Magn. Mater. 2005, 295, 251. [Google Scholar]
- 104. Zheng Y. X., Cao Q. Q., Zhang C. L., Xuan H. C., Wang L. Y., Wang D. H., Du Y. W., J. Appl. Phys. 2011, 110, 043908. [Google Scholar]
- 105. Li S., Cheng Z.‐Y., J. Appl. Phys. 2010, 107, 114514. [Google Scholar]
- 106. Johnson M. L., Wan J., Huang S., Cheng Z., Petrenko V. A., Kim D.‐J., Chen I.‐H., Barbaree J. M., Hong J. W., Chin B. A., Sens. Actuators, A 2008, 144, 38. [Google Scholar]
- 107. Grimes C. A., Ong K. G., Loiselle K., Stoyanov P. G., Kouzoudis D., Liu Y., Tong C., Tefiku F., Smart Mater. Struct. 1999, 8, 639. [Google Scholar]
- 108. Cai Q., Zeng K., Ruan C., Desai T. A., Grimes C. A., Anal. Chem. 2004, 76, 4038. [DOI] [PubMed] [Google Scholar]
- 109. Zhang K., Zhang K., Chai Y., AIP Adv. 2014, 4, 057114. [Google Scholar]
- 110. Zhang K., Chai Y., Cheng Z.‐Y., Sensors 2015, 15, 24585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111. Gao X., Pang P., Wu S., Yang W., Huang S., Cai Q., Grimes C. A., Anal. Lett. 2007, 40, 471. [Google Scholar]
- 112. Wu S., Gao X., Cai Q., Grimes C. A., Sens. Actuators, B 2007, 123, 856. [Google Scholar]
- 113. Guntupalli R., Hu J., Lakshmanan R. S., Huang T. S., Barbaree J. M., Chin B. A., Biosens. Bioelectron. 2007, 22, 1474. [DOI] [PubMed] [Google Scholar]
- 114. Fu L., Li S., Zhang K., Chen I.‐H., Petrenko V. A., Cheng Z., Sensors 2007, 7, 2929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. Li S., Fu L., Barbaree J. M., Cheng Z.‐Y., Sens. Actuators, B 2009, 137, 692. [Google Scholar]
- 116. Fu L., Zhang K., Li S., Wang Y., Huang T.‐S., Zhang A., Cheng Z.‐Y., Sens. Actuators, B 2010, 150, 220. [Google Scholar]
- 117. Fu L., Li S., Zhang K., Chen I.‐H., Barbaree J. M., Zhang A., Cheng Z., IEEE Sens. J. 2011, 11, 1684. [Google Scholar]
- 118. Zhang K., Fu L., Zhang L., Cheng Z.‐Y., Huang T.‐S., Biotechnol. Bioeng. 2014, 111, 2229. [DOI] [PubMed] [Google Scholar]
- 119. Ye X.‐M., Guntupalli R., Lakshmanan R. S., Chin B. A., Hu J., Mater. Sci. Eng., C 2014, 41, 78. [DOI] [PubMed] [Google Scholar]
- 120. Chen L., Li J., Thuy T. T. T., Zhou L., Huang C., Yuan L., Cai Q., Biosens. Bioelectron. 2014, 52, 427. [DOI] [PubMed] [Google Scholar]
- 121. Sang S., Li Y., Guo X., Zhang B., Xue X., Zhuo K., Zhao C., Zhang W., Yuan Z., Biosens. Bioelectron. 2019, 141, 111399. [DOI] [PubMed] [Google Scholar]
- 122. Wang J., Guo X., Liu R., Guo J., Zhang Y., Zhang W., Sang S., Nanotechnology 2020, 31, 015501. [DOI] [PubMed] [Google Scholar]
- 123. Edwards S., Fukusho A., Lefèvre P.‐C., Lipowski A., Pejsak Z., Roehe P., Westergaard J., Vet. Microbiol. 2000, 73, 103. [DOI] [PubMed] [Google Scholar]
- 124. Guo X., Gao S., Sang S., Jian A., Duan Q., Ji J., Zhang W., Biosens. Bioelectron. 2016, 82, 1127. [DOI] [PubMed] [Google Scholar]
- 125. Guo X., Sang S., Guo J., Jian A., Duan Q., Ji J., Zhang Q., Zhang W., Sci. Rep. 2017, 7, 15626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126. Shindo Y., Mori K., Narita F., Acta Mech. 2010, 212, 253. [Google Scholar]
- 127. Khizroev S., Cold Spring Harbor Perspect. Med. 2019, 9, a034207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128. Zhao Z., Wang B., Zhu J., Qian Z., Huang B., IEEE Trans. Ultrason., Ferroelectr., Freq. Control 2019, 66, 1331. [DOI] [PubMed] [Google Scholar]
- 129. Zhao X., Zhao Z., Wang B., Qian Z., Sensors 2020, 20, 2408.32340295 [Google Scholar]
- 130. Narita F., Shindo Y., Sato K., Comput. Struct. 2011, 89, 1077. [Google Scholar]
- 131. Jia Y., Wei X., Xu L., Wang C., Lian P., Xue S., Al‐Saadi A., Shi Y., Composites, Part B 2019, 161, 376. [Google Scholar]
- 132. Liu Y., Du S., Micallef C., Jia Y., Shi Y., Hughes D. J., Energies 2020, 13, 2720. [Google Scholar]
- 133. Liu R., Fu A., Deng Z., Li Y., Liu T., VIEW 2020, 1, e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Integrated workflows for real‐time detection and monitoring of SARS‐CoV‐2, https://nanoporetech.com/ (accessed: August 2020).
- 135. Rahmani A. R., Leili M., Azarian G., Poormohammadi A., Sci. Total Environ. 2020, 740, 140207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136. Jadi A., Int. J. Adv. Comput. Sci. Appl. 2020, 11, 165. [Google Scholar]
- 137. Fouad H., Hassanein A. S., Soliman A. M., Al‐Feel H., Measurement 2020, 159, 107757. [Google Scholar]
- 138. Zuo B., Li S., Guo Z., Zhang J., Chen C., Anal. Chem. 2004, 76, 3536. [DOI] [PubMed] [Google Scholar]
- 139. Pandey L. M., Expert Rev. Proteomics 2020, 17, 425. [DOI] [PubMed] [Google Scholar]